The Oncosearch | Oncotarget

Reelin promotes the adhesion and drug resistance of multiple myeloma cells via integrin Î²1 signaling and STAT3 Research Paper

Liang Lin, Fan Yan, Dandan Zhao, Meng Lv, Xiaodong Liang, Hui Dai, Xiaodan Qin, Yan Zhang, Jie Hao, Xiuyuan Sun, Yanhui Yin, Xiaojun Huang, Jun Zhang, Jin Lu, Qing Ge

Published Feb 3, 2016 · Vol. 7, No. 9 · pp. 9844-9858

A novel small molecule agent displays potent anti-myeloma activity by inhibiting the JAK2-STAT3 signaling pathway Research Paper

Zubin Zhang, Hongwu Mao, Xiaolin Du, Jingyu Zhu, Yujia Xu, Siyu Wang, Xin Xu, Peng Ji, Yang Yu, Biyin Cao, Kunkun Han, Tingjun Hou, Zhuan Xu, Yan Kong, Gaofeng Jiang, Xiaowen Tang, Chunhua Qiao, Xinliang Mao

Published Jan 22, 2016 · Vol. 7, No. 8 · pp. 9296-9308

miRNA-29a as a tumor suppressor mediates PRIMA-1^Met-induced anti-myeloma activity by targeting c-Myc Research Paper

Manujendra N. Saha, Jahangir Abdi, Yijun Yang, Hong Chang

Published Jan 11, 2016 · Vol. 7, No. 6 · pp. 7149-7160

Genome-wide profiling of histone H3 lysine 27 and lysine 4 trimethylation in multiple myeloma reveals the importance of Polycomb gene targeting and highlights EZH2 as a potential therapeutic target Research Paper

Prasoon Agarwal, Mohammad Alzrigat, Alba Atienza PÃ¡rraga, Stefan Enroth, Umashankar Singh, Johanna Ungerstedt, Anders Ã–sterborg, Peter J. Brown, Anqi Ma, Jian Jin, Kenneth Nilsson, Fredrik Ã–berg, Antonia Kalushkova, Helena Jernberg-Wiklund

Published Jan 7, 2016 · Vol. 7, No. 6 · pp. 6809-6823

Wogonin inhibits multiple myeloma-stimulated angiogenesis via c-Myc/VHL/HIF-1α signaling axis Research Paper

Rong Fu, Yan Chen, Xiao-Ping Wang, Teng An, Lei Tao, Yu-Xin Zhou, Yu-Jie Huang, Bao-An Chen, Zhi-Yu Li, Qi-Dong You, Qing-Long Guo, Zhao-Qiu Wu

Published Dec 30, 2015 · Vol. 7, No. 5 · pp. 5715-5727

Inhibiting the anaphase promoting complex/cyclosome induces a metaphase arrest and cell death in multiple myeloma cells Research Paper

Susanne Lub, Anke Maes, Ken Maes, Kim De Veirman, Elke De Bruyne, Eline Menu, Karel Fostier, Alboukadel Kassambara, JÃ©rÃ´me Moreaux, Dirk Hose, Xavier Leleu, Randall W. King, Karin Vanderkerken, Els Van Valckenborgh

Published Dec 26, 2015 · Vol. 7, No. 4 · pp. 4062-4076

Novel strategies to target the ubiquitin proteasome system in multiple myeloma Review

Susanne Lub, Ken Maes, Eline Menu, Elke De Bruyne, Karin Vanderkerken, Els Van Valckenborgh

Published Dec 18, 2015 · Vol. 7, No. 6 · pp. 6521-6537

MTDH is an oncogene in multiple myeloma, which is suppressed by Bortezomib treatment Research Paper

Chunyan Gu, Lang Feng, Hailin Peng, Hongbao Yang, Zhenqing Feng, Ye Yang

Published Dec 14, 2015 · Vol. 7, No. 4 · pp. 4559-4569

Molecular evidence of Zn chelation of the procaspase activating compound B-PAC-1 in B cell lymphoma Research Paper

Aloke Sarkar, Kumudha Balakrishnan, Jefferson Chen, Viralkumar Patel, Sattva S. Neelapu, John S. McMurray, Varsha Gandhi

Published Dec 7, 2015 · Vol. 7, No. 3 · pp. 3461-3476

Targeting heparanase overcomes chemoresistance and diminishes relapse in myeloma Research Paper

Vishnu C. Ramani, Fenghuang Zhan, Jianbo He, Paola Barbieri, Alessandro Noseda, Guido Tricot, Ralph D. Sanderson

Published Nov 27, 2015 · Vol. 7, No. 2 · pp. 1598-1607

Mechanisms for autophagy modulation by isoprenoid biosynthetic pathway inhibitors in multiple myeloma cells Research Paper

Kaitlyn M. Dykstra, Cheryl Allen, Ella J. Born, Huaxiang Tong, Sarah A. Holstein

Published Nov 22, 2015 · Vol. 6, No. 39 · pp. 41535-41549

The genetic and genomic background of multiple myeloma patients achieving complete response after induction therapy with bortezomib, thalidomide and dexamethasone (VTD) Research Paper

Carolina Terragna, Daniel Remondini, Marina Martello, Elena Zamagni, Lucia Pantani, Francesca Patriarca, Annalisa Pezzi, Giuseppe Levi, Massimo Offidani, Ilaria Proserpio, Giovanni De Sabbata, Paola Tacchetti, Clotilde Cangialosi, Fabrizio Ciambelli, Clara Virginia ViganÃ², Flores Angela Dico, Barbara Santacroce, Enrica Borsi, Annamaria Brioli, Giulia Marzocchi, Gastone Castellani, Giovanni Martinelli, Antonio Palumbo, Michele Cavo

Published Nov 9, 2015 · Vol. 7, No. 9 · pp. 9666-9679

The bone marrow microenvironment enhances multiple myeloma progression by exosome-mediated activation of myeloid-derived suppressor cells Research Paper

Jinheng Wang, Kim De Veirman, Nathan De Beule, Ken Maes, Elke De Bruyne, Els Van Valckenborgh, Karin Vanderkerken, Eline Menu

Published Nov 2, 2015 · Vol. 6, No. 41 · pp. 43992-44004

Disentangling the microRNA regulatory milieu in multiple myeloma: integrative genomics analysis outlines mixed miRNA-TF circuits and pathway-derived networks modulated in t(4;14) patients Research Paper

Enrica Calura, Andrea Bisognin, Martina Manzoni, Katia Todoerti, Elisa Taiana, Gabriele Sales, Gareth J. Morgan, Giovanni Tonon, Nicola Amodio, Pierfrancesco Tassone, Antonino Neri, Luca Agnelli, Chiara Romualdi, Stefania Bortoluzzi

Published Oct 19, 2015 · Vol. 7, No. 3 · pp. 2367-2378

UCHL1 is a biomarker of aggressive multiple myeloma required for disease progression Research Paper

Sajjad Hussain, Tibor Bedekovics, Marta Chesi, P. Leif Bergsagel, Paul J. Galardy

Published Oct 19, 2015 · Vol. 6, No. 38 · pp. 40704-40718

Myeloma cells can corrupt senescent mesenchymal stromal cells and impair their anti-tumor activity Research Paper

Umberto Galderisi, Servet Ã–zcan, Nicola Alessio, Mustafa Burak Acar, Guler Toprak, Zeynep Burcin Onal, Gianfranco Peluso

Published Oct 16, 2015 · Vol. 6, No. 37 · pp. 39482-39492

Serum levels of soluble programmed death ligand 1 predict treatment response and progression free survival in multiple myeloma Research Paper

Liang Wang, Hua Wang, Hao Chen, Wei-da Wang, Xiao-qin Chen, Qi-rong Geng, Zhong-jun Xia, Yue Lu

Published Oct 16, 2015 · Vol. 6, No. 38 · pp. 41228-41236

Junctional adhesion molecule-A is overexpressed in advanced multiple myeloma and determines response to oncolytic reovirus Research Paper

Kevin R. Kelly, Claudia M. Espitia, Weiguo Zhao, Erik Wendlandt, Guido Tricot, Fenghuang Zhan, Jennifer S. Carew, Steffan T. Nawrocki

Published Oct 15, 2015 · Vol. 6, No. 38 · pp. 41275-41289

Direct inhibition of c-Myc-Max heterodimers by celastrol and celastrol-inspired triterpenoids Priority Research Paper

Huabo Wang, Peter Teriete, Angela Hu, Dhanya Raveendra-Panickar, Kelsey Pendelton, John S. Lazo, Julie Eiseman, Toril Holien, Kristine Misund, Ganna Oliynyk, Marie Arsenian-Henriksson, Nicholas D. P. Cosford, Anders Sundan, Edward V. Prochownik

Published Oct 14, 2015 · Vol. 6, No. 32 · pp. 32380-32395

miRNAs in multiple myeloma â€“ a survival relevant complex regulator of gene expression Research Paper

Anja Seckinger, Tobias MeiÃŸner, JÃ©rÃ´me Moreaux, Vladimir Benes, Jens Hillengass, Mirco Castoldi, JÃ¼rgen Zimmermann, Anthony D. Ho, Anna Jauch, Hartmut Goldschmidt, Bernard Klein, Dirk Hose

Published Oct 12, 2015 · Vol. 6, No. 36 · pp. 39165-39183

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Reelin promotes the adhesion and drug resistance of multiple myeloma cells via integrin Î²1 signaling and STAT3 Research Paper

A novel small molecule agent displays potent anti-myeloma activity by inhibiting the JAK2-STAT3 signaling pathway Research Paper

miRNA-29a as a tumor suppressor mediates PRIMA-1^Met-induced anti-myeloma activity by targeting c-Myc Research Paper

Genome-wide profiling of histone H3 lysine 27 and lysine 4 trimethylation in multiple myeloma reveals the importance of Polycomb gene targeting and highlights EZH2 as a potential therapeutic target Research Paper

Wogonin inhibits multiple myeloma-stimulated angiogenesis via c-Myc/VHL/HIF-1α signaling axis Research Paper

Inhibiting the anaphase promoting complex/cyclosome induces a metaphase arrest and cell death in multiple myeloma cells Research Paper

Novel strategies to target the ubiquitin proteasome system in multiple myeloma Review

MTDH is an oncogene in multiple myeloma, which is suppressed by Bortezomib treatment Research Paper

Molecular evidence of Zn chelation of the procaspase activating compound B-PAC-1 in B cell lymphoma Research Paper

Targeting heparanase overcomes chemoresistance and diminishes relapse in myeloma Research Paper

Mechanisms for autophagy modulation by isoprenoid biosynthetic pathway inhibitors in multiple myeloma cells Research Paper

The genetic and genomic background of multiple myeloma patients achieving complete response after induction therapy with bortezomib, thalidomide and dexamethasone (VTD) Research Paper

The bone marrow microenvironment enhances multiple myeloma progression by exosome-mediated activation of myeloid-derived suppressor cells Research Paper

Disentangling the microRNA regulatory milieu in multiple myeloma: integrative genomics analysis outlines mixed miRNA-TF circuits and pathway-derived networks modulated in t(4;14) patients Research Paper

UCHL1 is a biomarker of aggressive multiple myeloma required for disease progression Research Paper

Myeloma cells can corrupt senescent mesenchymal stromal cells and impair their anti-tumor activity Research Paper

Serum levels of soluble programmed death ligand 1 predict treatment response and progression free survival in multiple myeloma Research Paper

Junctional adhesion molecule-A is overexpressed in advanced multiple myeloma and determines response to oncolytic reovirus Research Paper

Direct inhibition of c-Myc-Max heterodimers by celastrol and celastrol-inspired triterpenoids Priority Research Paper

miRNAs in multiple myeloma â€“ a survival relevant complex regulator of gene expression Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Reelin promotes the adhesion and drug resistance of multiple myeloma cells via integrin Î²1 signaling and STAT3 Research Paper

A novel small molecule agent displays potent anti-myeloma activity by inhibiting the JAK2-STAT3 signaling pathway Research Paper

miRNA-29a as a tumor suppressor mediates PRIMA-1Met-induced anti-myeloma activity by targeting c-Myc Research Paper

Genome-wide profiling of histone H3 lysine 27 and lysine 4 trimethylation in multiple myeloma reveals the importance of Polycomb gene targeting and highlights EZH2 as a potential therapeutic target Research Paper

Wogonin inhibits multiple myeloma-stimulated angiogenesis via c-Myc/VHL/HIF-1α signaling axis Research Paper

Inhibiting the anaphase promoting complex/cyclosome induces a metaphase arrest and cell death in multiple myeloma cells Research Paper

Novel strategies to target the ubiquitin proteasome system in multiple myeloma Review

MTDH is an oncogene in multiple myeloma, which is suppressed by Bortezomib treatment Research Paper

Molecular evidence of Zn chelation of the procaspase activating compound B-PAC-1 in B cell lymphoma Research Paper

Targeting heparanase overcomes chemoresistance and diminishes relapse in myeloma Research Paper

Mechanisms for autophagy modulation by isoprenoid biosynthetic pathway inhibitors in multiple myeloma cells Research Paper

The genetic and genomic background of multiple myeloma patients achieving complete response after induction therapy with bortezomib, thalidomide and dexamethasone (VTD) Research Paper

The bone marrow microenvironment enhances multiple myeloma progression by exosome-mediated activation of myeloid-derived suppressor cells Research Paper

Disentangling the microRNA regulatory milieu in multiple myeloma: integrative genomics analysis outlines mixed miRNA-TF circuits and pathway-derived networks modulated in t(4;14) patients Research Paper

UCHL1 is a biomarker of aggressive multiple myeloma required for disease progression Research Paper

Myeloma cells can corrupt senescent mesenchymal stromal cells and impair their anti-tumor activity Research Paper

Serum levels of soluble programmed death ligand 1 predict treatment response and progression free survival in multiple myeloma Research Paper

Junctional adhesion molecule-A is overexpressed in advanced multiple myeloma and determines response to oncolytic reovirus Research Paper

Direct inhibition of c-Myc-Max heterodimers by celastrol and celastrol-inspired triterpenoids Priority Research Paper

miRNAs in multiple myeloma â€“ a survival relevant complex regulator of gene expression Research Paper

miRNA-29a as a tumor suppressor mediates PRIMA-1^Met-induced anti-myeloma activity by targeting c-Myc Research Paper